PONIARD PHARMACEUTICALS, INC. 4
4 · PONIARD PHARMACEUTICALS, INC. · Filed Jan 4, 2008
Insider Transaction Report
Form 4
KARLIN DAVID A
Sr. VP, Clinical Devlpt & Reg
Transactions
- Award
Stock Option
2008-01-03$4.18/sh+40,000$167,200→ 40,000 totalExercise: $4.18Exp: 2018-01-03→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Exercisable in equal monthly installments of 1/48th per month beginning 2/3/2008 in accordance with the vesting schedule of the Amended and Restated Poniard 2004 Incentive Compensation Plan.